{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/d8/federal/","compound":{"slug":"d8","name":"Delta-8 THC"},"federal":[{"form":"all","status":"gray","headline":"Delta-8 THC - federally contested: hemp by plain text per the 9th and 4th Circuits, Schedule I on DEA's synthetic-conversion theory; exclude","tier":"under_review","schedule_class":null,"effective_date":"2018-12-20","verified_at":"2026-09-23","citations":[{"title":"21 CFR 1308.11 - Schedule I, including (d)(31) tetrahydrocannabinols (drug code 7370) and the (d)(31)(ii) hemp exclusion","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"7 U.S.C. 1639o - definition of hemp (Agricultural Marketing Act of 1946 sec. 297A)","url":"https://uscode.house.gov/view.xhtml?req=(title:7%20section:1639o%20edition:prelim)","pinpoint":null,"primary":true},{"title":"Letter, Terrence L. Boos, Ph.D., DEA, to Donna Yeatman, R.Ph., Executive Secretary, Alabama Board of Pharmacy, September 15, 2021 - delta-8 THC","url":"https://albop.com/oodoardu/2021/10/ALBOP-synthetic-delta8-THC-21-7520-signed.pdf","pinpoint":null,"primary":true},{"title":"AK Futures LLC v. Boyd Street Distro, LLC, 35 F.4th 682 (9th Cir. 2022) (No. 21-56133)","url":"https://cdn.ca9.uscourts.gov/datastore/opinions/2022/05/19/21-56133.pdf","pinpoint":null,"primary":true},{"title":"Anderson v. Diamondback Investment Group, LLC (4th Cir. 2024) (No. 23-1400)","url":"https://www.ca4.uscourts.gov/opinions/231400.p.pdf","pinpoint":null,"primary":true},{"title":"Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance (DEA final rule, 91 FR 23913, FR Doc. 2026-08595)","url":"https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance","pinpoint":null,"primary":true},{"title":"Pub. L. 119-37, div. B, tit. VII, sec. 781 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026; H.R. 5371), 139 Stat. 558","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","pinpoint":null,"primary":true},{"title":"21 U.S.C. 812, Schedule I(c)(17) - tetrahydrocannabinols","url":"https://uscode.house.gov/view.xhtml?req=(title:21%20section:812%20edition:prelim)","pinpoint":null,"primary":true},{"title":"21 CFR 1308.11(d)(31)","url":"https://www.ecfr.gov/current/title-21/section-1308.11","pinpoint":null,"primary":true},{"title":"Federal Register full-text sweep, 2025-01-01 through 2026-07-25 (Federal Register API, agency and term filtered)","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"Statutory deadline for the Pub. L. 119-37 sec. 781(3) FDA cannabinoid lists (due on or about 2026-02-10) - not published as of 2026-07-25","url":"https://www.federalregister.gov/api/v1/documents.json","pinpoint":null,"primary":false},{"title":"UN Commission on Narcotic Drugs scheduling decisions, 68th session (March 2025) and 69th session (March 2026); WHO Expert Committee on Drug Dependence 47th and 48th meetings","url":"https://www.unodc.org/unodc/en/commissions/CND/Mandate_Functions/current-scheduling-decisions.html","pinpoint":null,"primary":false}]}]}